Olmesartan medoxomil-

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 560 publications

The Impact of Minimal Residual Disease (MRD) Testing on the Decision-Making Process in Non-Small-Cell Lung Cancer (NSCLC).

The Impact of Minimal Residual Disease (MRD) Testing on the Decision-Making Process in Non-Small-Cell Lung Cancer (NSCLC).

Journal: Cancers
Published: March 16, 2026

Impact of the national centralized volume-based procurement policy on antihypertensive drug procurement, price, and volume in Guangxi: an interrupted time series analysis of procurement data.

Impact of the national centralized volume-based procurement policy on antihypertensive drug procurement, price, and volume in Guangxi: an interrupted time series analysis of procurement data.

Journal: Frontiers in pharmacology
Published: February 13, 2026

Green Metric Assessment of Analytical Techniques for the Imidazole Prodrug Olmesartan Medoxomil: A Comparative Analysis.

Green Metric Assessment of Analytical Techniques for the Imidazole Prodrug Olmesartan Medoxomil: A Comparative Analysis.

Journal: Critical reviews in analytical chemistry
Published: December 02, 2025

Stability of Olmesartan Medoxomil Tablets in Unit-Dose Packaging With Metformin Hydrochloride Tablets.

Stability of Olmesartan Medoxomil Tablets in Unit-Dose Packaging With Metformin Hydrochloride Tablets.

Journal: Cureus
Published: October 28, 2025

Enhancing Oral Absorption of an Ester Prodrug by Coating Drug Crystals with Binary Lipid Systems and Evaluating the Influence of Compositions.

Enhancing Oral Absorption of an Ester Prodrug by Coating Drug Crystals with Binary Lipid Systems and Evaluating the Influence of Compositions.

Journal: Pharmaceutics
Published: August 06, 2025

Development and Evaluation of a Modified Fixed-Dose Combination Antihypertensive Tablet Containing S-Amlodipine Besylate: A Bioequivalence and Stability Study.

Development and Evaluation of a Modified Fixed-Dose Combination Antihypertensive Tablet Containing S-Amlodipine Besylate: A Bioequivalence and Stability Study.

Journal: Pharmaceutics
Published: July 28, 2025

Advanced lipid-based niosomes for enhanced transdermal delivery of olmesartan medoxomil via intracutaneous drug depot: a novel biomimicry approach.

Advanced lipid-based niosomes for enhanced transdermal delivery of olmesartan medoxomil via intracutaneous drug depot: a novel biomimicry approach.

Journal: Drug delivery and translational research
Published: June 05, 2025

Design of Experiments (DoE) Driven Fabrication of Surface Modified Liposomes of Olmesartan Medoxomil for Improved Oral Bioavailability.

Design of Experiments (DoE) Driven Fabrication of Surface Modified Liposomes of Olmesartan Medoxomil for Improved Oral Bioavailability.

Journal: AAPS PharmSciTech
Published: June 04, 2025

Multi-way calibration strategies involving excitation-emission data measurements from drug-modulated fluorescence in CdTe quantum dots and AgInS2 nanocrystals.

Multi-way calibration strategies involving excitation-emission data measurements from drug-modulated fluorescence in CdTe quantum dots and AgInS2 nanocrystals.

Journal: Analytica chimica acta
Published: May 12, 2025

The impact of epiretinal membrane stage and postoperative treatment on visual and anatomical outcomes following vitrectomy in eyes with preexisting macular edema.

The impact of epiretinal membrane stage and postoperative treatment on visual and anatomical outcomes following vitrectomy in eyes with preexisting macular edema.

Journal: International journal of retina and vitreous
Published: May 04, 2025

Effectiveness of single-pill combination olmesartan/amlodipine/hydrochlorothiazide therapy in patients with apparent resistant hypertension.

Effectiveness of single-pill combination olmesartan/amlodipine/hydrochlorothiazide therapy in patients with apparent resistant hypertension.

Journal: Journal of human hypertension
Published: March 04, 2025

Gastroretentive microballoons of olmesartan medoxomil: formulation and in vitro-in vivo evaluation.

Gastroretentive microballoons of olmesartan medoxomil: formulation and in vitro-in vivo evaluation.

Journal: Therapeutic delivery
Published: February 25, 2025
Showing 1-12 of 560

Last Updated: 09/26/2026